Caribou Biosciences Inc (NASDAQ: CRBU) on Tuesday, soared 3.85% from the previous trading day, before settling in for the closing price of $2.34. Within the past 52 weeks, CRBU’s price has moved between $0.66 and $3.00.
Annual sales at Healthcare sector company slipped by -33.41% over the past five years. The company achieved an average annual earnings per share of 0.06%. With a float of $82.13 million, this company’s outstanding shares have now reached $93.12 million.
Caribou Biosciences Inc (CRBU) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Caribou Biosciences Inc is 11.80%, while institutional ownership is 40.84%. The most recent insider transaction that took place on Mar 14 ’25, was worth 20,400. In this transaction President and CEO of this company bought 20,000 shares at a rate of $1.02, taking the stock ownership to the 3,369,395 shares. Before that another transaction happened on Feb 21 ’25, when Company’s Chief Legal Officer sold 3,564 for $1.35, making the entire transaction worth $4,811. This insider now owns 443,502 shares in total.
Caribou Biosciences Inc (CRBU) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.38 earnings per share (EPS) for the period topping the consensus outlook (set at -0.45) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.99% during the next five years compared to -33.41% drop over the previous five years of trading.
Caribou Biosciences Inc (NASDAQ: CRBU) Trading Performance Indicators
Caribou Biosciences Inc (CRBU) is currently performing well based on its current performance indicators. A quick ratio of 6.66 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.79, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Caribou Biosciences Inc (CRBU)
Caribou Biosciences Inc (NASDAQ: CRBU) saw its 5-day average volume 1.32 million, a positive change from its year-to-date volume of 1.28 million. As of the previous 9 days, the stock’s Stochastic %D was 89.04%.
During the past 100 days, Caribou Biosciences Inc’s (CRBU) raw stochastic average was set at 87.84%, which indicates a significant decrease from 98.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was higher than the 0.15 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.95, while its 200-day Moving Average is $1.43. Nevertheless, the first resistance level for the watch stands at $2.50 in the near term. At $2.57, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.70. If the price goes on to break the first support level at $2.30, it is likely to go to the next support level at $2.17. The third support level lies at $2.10 if the price breaches the second support level.
Caribou Biosciences Inc (NASDAQ: CRBU) Key Stats
Market capitalization of the company is 226.29 million based on 93,123K outstanding shares. Right now, sales total 9,990 K and income totals -149,110 K. The company made 2,670 K in profit during its latest quarter, and -54,100 K in sales during its previous quarter.
